Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00354120
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2006-07-19
Brief Title:
Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant
Sponsor:
Organization:
Gruppo Italiano Trapianto di Midollo Osseo